M.Sc

National JALMA Institute for Leprosy and Other Mycobacterial Diseases (ICMR),Tajganj, Agra – 282 001 invites application for filling up the adhoc posts of Contractual Microbiologist (01), Research Associate (01), Research Assistant (5)and JRF (02), SRF (01) and Laboratory Attendant (01) in various ongoing extramural projects funded by ICMR/CSIR/DBT/ICAR/CTD-Govt of India. These posts are purely temporary and on a project mode.

National Institute of Pharmaceutical Education and Research (NIPER) is the first national level institute in pharmaceutical sciences with a proclaimed objective of becoming a centre of excellence for advanced studies and research in pharmaceutical sciences. The Government of India has declared NIPER as an ‘Institute of National Importance’.

The National Dairy Development Board (NDDB) set up Indian Immunologicals Ltd. (IIL) in 1982 with the objective of making Foot and Mouth Disease (FMD) vaccine available to farmers at an affordable price. The technology for FMD vaccine manufacture was obtained from M/s. Wellcome Foundation Limited, United Kingdom. The plant in Hyderabad today has a capacity to make 80 million trivalent doses of FMD vaccine.

IOL Chemicals and Pharmaceuticals Limited (IOLCP) is a leading organic chemicals manufacturer and supplier. We are Indian manufacturer of industrial chemicals & bulk drugs for over two decades. By pursuing & implementing the highest standards of excellence in our operations, we have nurtured our capabilities. By delivering consistent results have earned the admiration of customers and stakeholders alike.

Spansules was established in the year 2000 and commenced commercial manufacturing of Pre-formulation Pharmaceuticals at Hyderabad. Today Spansules has a manufacturing facility within the premises of Pharmaceuticals hub of Hyderabad . The facility was equipped with sophisticated equipments like, fluidized bed coater, Extruders, Spheronisers etc.

“ELICO” The name which pioneered and gave new meaning and direction to the word Analytical Instrumentation in India and electronics in state of Andhra Pradesh, and this word “Electronics” has now become the identity of Hyderabad. The company commenced its operations in 1959 slightly more than a decade after Independence of Country. It was a time when there were very few players nationally in the technology arena and none locally.

About Author:
Mr. Jagmohan Rai Agarwal,
M.Pharm (1968), Industrial experience SSI sector, nearly 37 years, retired from own Industry,
Founder President of M.P.Pharmacy Graduates’ Association,
President: M.P.Pharmaceutical Manufacturers’ Organisation,
Founder President : M.P. Small Scale Drug Manufacturers’ Association,
President Indian Pharmaceutical Association, M.P. State Branch, Indore,
Recently submitted thesis for award of  Ph.D. on title “Enforcement of Drug Laws-Globalization vis-à-vis Indian Drug Laws”
(Email: sharda_jollo@yahoo.co.in)

Quality of Pharmaceuticals has been a concern of the World Health Organisation (WHO) since its inception. The setting of global standards is requested in Article 2 of the WHO constitution which sites as one of the organisation’s functions that it should develop, establish and promote International standards with respect to food, biological, pharmaceuticals and similar products.

Campbell (US FDA) was the first leading architect of the present Federal Food, Drug and Cosmetics Act passed in 1938. He differed sharply with ‘Willey’ in his belief that Court proceedings were not the only proper way to secure compliance.

Cadila Pharmaceuticals Ltd., one of the largest Indian pharmaceutical companies has presence in 90 countries across the globe catering to over 45 therapeutic areas. The company has one of the best R&D setup in India which forms the backbone of our state-of-the-art manufacturing facilities in India and abroad, approved by various regulatory authorities including USFDA, MHRA (UK).